DE69332541D1 - Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämie - Google Patents
Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämieInfo
- Publication number
- DE69332541D1 DE69332541D1 DE69332541T DE69332541T DE69332541D1 DE 69332541 D1 DE69332541 D1 DE 69332541D1 DE 69332541 T DE69332541 T DE 69332541T DE 69332541 T DE69332541 T DE 69332541T DE 69332541 D1 DE69332541 D1 DE 69332541D1
- Authority
- DE
- Germany
- Prior art keywords
- pct
- thrombozythemia
- hemorrhagic
- consuming
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929214489A GB9214489D0 (en) | 1992-07-08 | 1992-07-08 | Pharmaceutical compositions and uses therefor |
GB939301251A GB9301251D0 (en) | 1993-01-22 | 1993-01-22 | Pharmaceutical compositions and use therefor |
PCT/EP1993/001790 WO1994001123A1 (en) | 1992-07-08 | 1993-07-08 | Pharmaceutical composition containing il-6, their uses for the treatment of consumptive thrombo-hemorrhagic disorder |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69332541D1 true DE69332541D1 (de) | 2003-01-16 |
DE69332541T2 DE69332541T2 (de) | 2003-04-17 |
Family
ID=26301225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69332541T Expired - Fee Related DE69332541T2 (de) | 1992-07-08 | 1993-07-08 | Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämie |
Country Status (13)
Country | Link |
---|---|
US (1) | US5925344A (de) |
EP (1) | EP0651648B1 (de) |
JP (1) | JP3845112B2 (de) |
AT (1) | ATE228848T1 (de) |
AU (1) | AU674864B2 (de) |
CA (1) | CA2139353C (de) |
DE (1) | DE69332541T2 (de) |
DK (1) | DK0651648T3 (de) |
ES (1) | ES2183814T3 (de) |
IL (1) | IL106272A (de) |
MX (1) | MX9304075A (de) |
PT (1) | PT651648E (de) |
WO (1) | WO1994001123A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE343792T1 (de) * | 1999-02-19 | 2006-11-15 | Univ Iowa Res Found | Diagnostika und therapeutika für maculare degeneration |
US7108982B1 (en) | 1999-02-19 | 2006-09-19 | University Of Iowa Research Foundation | Diagnostics and the therapeutics for macular degeneration |
EP1066834A3 (de) * | 1999-07-08 | 2004-06-02 | Thomas Dr. Stief | Pharmazeutische Zusammensetzungen enthaltend ein phagozytenmodulierendes Agens |
CN1434703A (zh) * | 2000-08-24 | 2003-08-06 | 利统股份有限公司 | 延迟释放组合物及组合 |
FI20041425A0 (fi) * | 2004-11-05 | 2004-11-05 | Orion Corp | Transmukosaalinen veterinäärinen koostumus |
RU2600876C2 (ru) * | 2009-10-16 | 2016-10-27 | Омерос Корпорейшен | Способ лечения диссеминированного внутрисосудистого свертывания крови путем ингибирования masp-2 зависимой активации комплемента |
US9644035B2 (en) | 2011-04-08 | 2017-05-09 | Omeros Corporation | Methods for treating conditions associated with MASP-2 dependent complement activation |
RU2477530C2 (ru) * | 2011-04-28 | 2013-03-10 | Общество С Ограниченной Ответственностью "Научно-Производственная Фирма "Материа Медика Холдинг" | Способ коррекции эндотелиальной дисфункции раствором гомеопатических разведений антител к интерлейкину-6 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5271931A (en) * | 1988-09-14 | 1993-12-21 | The Scripps Research Institute | Methods for increasing C1 inhibitor concentrations using interferon-gamma and/or interleukin-6 |
JPH0372429A (ja) * | 1988-10-07 | 1991-03-27 | Chugai Pharmaceut Co Ltd | 血小板減少症の治療剤 |
JP2805224B2 (ja) * | 1989-01-13 | 1998-09-30 | 味の素株式会社 | 血小板減少症治療剤 |
US5087448A (en) * | 1989-02-02 | 1992-02-11 | The Board Of Regents Of The University Of Oklahoma | Enhancing growth of megakaryocytes in mammals using interleuking 6 |
JPH04218000A (ja) * | 1990-02-13 | 1992-08-07 | Kirin Amgen Inc | 修飾ポリペプチド |
US5188828A (en) * | 1990-11-08 | 1993-02-23 | Brigham And Women's Hospital | Interleukin-6 to stimulate erythropoietin production |
WO1992008483A1 (en) * | 1990-11-13 | 1992-05-29 | The Children's Medical Center Corporation | CONTROLLING β-AMYLOID RELATED NEURONAL DEGENERATION BY ANTAGONIZING NGF-EFFECTED NEURONAL ACTIVITY |
EP0560998A4 (en) * | 1991-10-09 | 1993-12-01 | Toray Industries, Inc. | Medicine for preventing and treating bleeding tendency |
-
1993
- 1993-07-07 MX MX9304075A patent/MX9304075A/es not_active IP Right Cessation
- 1993-07-08 CA CA002139353A patent/CA2139353C/en not_active Expired - Fee Related
- 1993-07-08 US US08/367,124 patent/US5925344A/en not_active Expired - Fee Related
- 1993-07-08 WO PCT/EP1993/001790 patent/WO1994001123A1/en active IP Right Grant
- 1993-07-08 AT AT93915854T patent/ATE228848T1/de not_active IP Right Cessation
- 1993-07-08 DK DK93915854T patent/DK0651648T3/da active
- 1993-07-08 EP EP93915854A patent/EP0651648B1/de not_active Expired - Lifetime
- 1993-07-08 DE DE69332541T patent/DE69332541T2/de not_active Expired - Fee Related
- 1993-07-08 IL IL10627293A patent/IL106272A/en not_active IP Right Cessation
- 1993-07-08 AU AU45664/93A patent/AU674864B2/en not_active Ceased
- 1993-07-08 PT PT93915854T patent/PT651648E/pt unknown
- 1993-07-08 ES ES93915854T patent/ES2183814T3/es not_active Expired - Lifetime
- 1993-07-08 JP JP50297094A patent/JP3845112B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU4566493A (en) | 1994-01-31 |
MX9304075A (es) | 1994-04-29 |
IL106272A0 (en) | 1993-11-15 |
AU674864B2 (en) | 1997-01-16 |
CA2139353C (en) | 2006-11-07 |
DK0651648T3 (da) | 2003-01-06 |
ES2183814T3 (es) | 2003-04-01 |
IL106272A (en) | 1999-01-26 |
PT651648E (pt) | 2003-04-30 |
EP0651648B1 (de) | 2002-12-04 |
JP3845112B2 (ja) | 2006-11-15 |
EP0651648A1 (de) | 1995-05-10 |
ATE228848T1 (de) | 2002-12-15 |
DE69332541T2 (de) | 2003-04-17 |
CA2139353A1 (en) | 1994-01-20 |
US5925344A (en) | 1999-07-20 |
JPH08502028A (ja) | 1996-03-05 |
WO1994001123A1 (en) | 1994-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2166111T3 (es) | Uso de tiagabina para el tratamiento de trastornos del sueño. | |
DE69230112D1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
ATE185548T1 (de) | Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress | |
DE69317578T2 (de) | Verwendung von riluzole zur behandlung von traumatischen neurologischen-schädigungen | |
PT1011632E (pt) | Composicao farmaceutica para o tratamento de dismenorreia e parto prematuro | |
DE69831000D1 (de) | Verwendung von cytidin und cytosin-enthaltenden verbindungen zur behandlung von reizmittelgelgebrauch | |
DE69332541D1 (de) | Il-6 enthaltende pharmazeutische zusammensetzungen ihre verfahren zur behandlungder verbrauchenden hämorrhagischen thrombozythämie | |
DE69316013D1 (de) | Verwendung von phosphinate zur behandlung der osteoporose | |
SE9603725D0 (sv) | New teatment | |
ATE192656T1 (de) | Verfahren zur behandlung von patienten mit chronischer lebererkrankung | |
PT706395E (pt) | Uso de ropivacaina na preparacao duma composicao farmaceutica com efeito analgesico e bloqueio motor minimo | |
DE69023006T2 (de) | Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen. | |
ATE203162T1 (de) | Verfahren zur behandlung von chronischer prostatitis mit 17-beta-n-tertbutylcarbamoyl-4- aza-5 alpha-androst-1-en-3-one | |
SE9303068D0 (sv) | New use | |
ES2113549T3 (es) | Metodo para inhibir la replicacion de vih empleando il-4. | |
DE69927599D1 (de) | Verwendung von wachstumshormon und analoga davon für die behandlung von säugern mit familiärer hypercholesterolämie | |
ATE200865T1 (de) | Verwendung von phosphorderivaten von alkaloiden zur behandlung von endokrinopathien | |
FI952855A (fi) | Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö | |
MX9606137A (es) | Composiciones y metodos para el tratamiento de tumores. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH |
|
8339 | Ceased/non-payment of the annual fee |